Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Mar;50(3):1079-82.
doi: 10.1128/AAC.50.3.1079-1082.2006.

Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus

Longzhu Cui  1 , Eiji Tominaga, Hui-Min Neoh, Keiichi Hiramatsu
Affiliations

Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus

Longzhu Cui et al. Antimicrob Agents Chemother. 2006 Mar.

Abstract

We present here findings of a strong positive correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus (VISA). This correlation is related to cell wall thickening, suggesting that, similar to the case with vancomycin resistance in VISA, the physical barrier of a thickened cell wall may contribute to daptomycin resistance in S. aureus.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Comparison of vancomycin and daptomycin susceptibilities for a variety of S. aureus strains with different cell wall thicknesses. (A) Vancomycin and daptomycin susceptibilities were determined using an antibiotic gradient gel assay with BHI agar that contained top concentrations of vancomycin (5 mg/liter) and daptomycin (2 mg/liter). (B) Representative transmission electron microscopy and cell wall thickness of tested strains. Magnification, ×20,700. The values given under each panel are the means and standard deviations of cell wall thickness calculated from 30 cells for each strain. The photos and data are from our previous study (9).
FIG. 2.
FIG. 2.
Regression analysis of correlation between vancomycin and daptomycin susceptibilities and between cell wall thickness and daptomycin susceptibility. A significant correlation was seen in both between vancomycin and daptomycin susceptibilities (A) and cell wall thickness and daptomycin susceptibility (B).
See this image and copyright information in PMC

References

    1. Akins, R. L., and M. J. Rybak. 2001. Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob. Agents Chemother. 45:454-459. - PMC - PubMed
    1. Akins, R. L., and M. J. Rybak. 2000. In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model. Antimicrob. Agents Chemother. 44:1925-1929. - PMC - PubMed
    1. Alder, J. 2005. Daptomycin: a new drug class for the treatment of Gram-positive infections. Drugs Today (Barcelona) 41:81-90. - PubMed
    1. Cetinkaya, Y., P. Falk, and C. G. Mayhall. 2000. Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 13:686-707. - PMC - PubMed
    1. Cha, R., R. G. Grucz, Jr., and M. J. Rybak. 2003. Daptomycin dose-effect relationship against resistant gram-positive organisms. Antimicrob. Agents Chemother. 47:1598-1603. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources